In short. The assessment specific to this treatment: pregnancy and breastfeeding, active skin disease, immune conditions, allergy history, keloid tendency and expectation.
Key points
- What the patient expects decides whether the treatment can succeed.
- A patient who wants a shape change, a permanent change or a solution to skin that has aged structurally will be disappointed by a treatment that cannot produce any of those, however well it is performed.
Every injectable has a candidacy conversation, and the one for skin-quality treatment is short but specific. It is not the same as the conversation for a structural filler, because the material, the depth and the purpose are different. What follows is the assessment this treatment actually requires, and the answers that change the plan.
What the assessment asks about
Pregnancy and breastfeeding come first, and the honest answer is that the treatment is deferred rather than debated. Active skin disease in the treatment area, such as an infection, an open wound, an eczema or rosacea flare or an active acne outbreak, is treated first and injected later. A history of cold sores in the area is not a bar but is planned around. A known allergy to any component of what is proposed is a bar. A tendency to form keloid or hypertrophic scars is declared and changes which areas are treated.
The expectation question is clinical, not polite
What the patient expects decides whether the treatment can succeed. A patient who wants a shape change, a permanent change or a solution to skin that has aged structurally will be disappointed by a treatment that cannot produce any of those, however well it is performed.
Conditions and medicines that change the plan
Anything that suppresses the immune system changes how tissue responds and how likely an infection or a delayed reaction becomes, so it is declared at the assessment. Medicines that affect clotting change the bruising conversation. Conditions that affect connective tissue change how the skin behaves. None of these is automatically disqualifying, and all of them belong in the conversation before a course is planned rather than after a session has gone badly.
What is not a bar but is planned around
Age is not a bar. Sensitive skin is not a bar. A history of previous injectable treatment is not a bar, though it changes the assessment, because material already present affects how the area looks. Recent sun exposure, a recent device treatment or a recent peel are all reasons to schedule rather than to refuse. The pattern is that very little rules the treatment out permanently; a good deal of it changes the timing.
Reasons to defer rather than start
- Pregnant or breastfeeding, or actively trying to conceive during the course.
- An active infection, wound, or inflammatory flare in the treatment area.
- A course starting within days of a significant event, or in a month you cannot attend.
The question patients should ask themselves
Before the appointment, answer one question honestly: if the effect lasts four months and then fades completely, and the skin returns to exactly what it is now, would the course still have been worth it? Patients who answer yes are usually satisfied, because the treatment delivered what they expected. Patients who answer no are usually buying something the treatment does not sell, and it is better to find that out in the consultation than after the third session.
Frequently asked questions
Why is breastfeeding a reason to wait?
Because there is no good evidence about the treatment in that situation, and the honest position is uncertainty rather than reassurance. Waiting a few months costs nothing clinically, while an avoidable uncertainty introduced into a period when the patient is already stretched is not worth taking. The decision belongs to the patient, informed by a clinician who says plainly that the evidence is absent.
I have an autoimmune condition. Can I still have this?
It depends on the condition, on how active it is and on the medication being taken. Some treatments that suppress the immune system change how tissue responds and how likely an infection or a delayed reaction becomes. This is a question for the clinician who manages that condition as well as for the injector, and it is worth asking both before booking.
Does a history of keloid scars rule it out?
Not automatically, but it changes the plan and the areas that are treated. A tendency to form raised scars matters more where the skin is under tension and more for treatments that create a wound. For a series of pinpoint injections the risk is low, but it is declared at the assessment rather than discovered afterwards.
Risks & Limitations
- Bruising and pinpoint marks are expected after a session and usually settle within a few days.
- Small bumps can appear where the material is placed, most often under the eyes, and most flatten on their own.
- An uneven result is possible, and a further session may be needed to even it.
- Infection or a delayed reaction at a treated area is uncommon and should be reviewed rather than waited out.
- The effect fades over months and the skin returns towards its earlier state. It cannot be made permanent, and no result can be guaranteed.
When to Seek Care
- Difficulty breathing, chest pain or swelling of the face or throat: seek emergency care immediately.
- Redness, warmth, swelling or discharge spreading from an injection point.
- A lump that is growing, or that is painful rather than tender.
- Blistering, patchy discolouration of the skin, or any change in vision or in sensation around a treated area.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.